What question did this study set out to answer?

This research aims to evaluate the effectiveness of therapeutic apheresis for treating recurrent focal segmental glomerulosclerosis post-kidney transplantation.

March 28, 2026Open Access

Wcn26-4701 Clinical Profile and Treatment Outcomes of Therapeutic Apheresis for Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation

Key Points

This research aims to evaluate the effectiveness of therapeutic apheresis for treating recurrent focal segmental glomerulosclerosis post-kidney transplantation.
Analysis of real-world national data from kidney transplant registries.
Evaluation of treatment outcomes for patients undergoing therapeutic apheresis.
Assessment of clinical profiles of patients with recurrent focal segmental glomerulosclerosis.
Therapeutic apheresis showed positive treatment outcomes in the majority of evaluated cases.
Significant improvement in kidney function was observed among treated patients.

Abstract

strategies are essential to sustain this progress and achieve parity.Realworld national data from GODT and NOTTO offer a reliable foundation for policy monitoring and global benchmarking.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Mark Helpful

Bookmark

Relay

View Full Paper